Author:
Tan Cedric C. S.,Kelly Gavin,Cregan Jack,Wilson Joseph D.,James Tim,Chand Meera,Hopkins Susan,Swets Maaike,Baillie J. Kenneth,Jeffery Katie,Walker Ann Sarah,Eyre David W.,Stoesser Nicole,Matthews Philippa C.
Abstract
Abstract
Background
An outbreak of acute severe hepatitis of unknown aetiology (AS-Hep-UA) in children during 2022 was subsequently linked to infections with adenovirus-associated virus 2 and other ‘helper viruses’, including human adenovirus. It is possible that evidence of such an outbreak could be identified at a population level based on routine data captured by electronic health records (EHR).
Methods
We used anonymised EHR to collate retrospective data for all emergency presentations to Oxford University Hospitals NHS Foundation Trust in the UK, between 2016–2022, for all ages from 18 months and older. We investigated clinical characteristics and temporal distribution of presentations of acute hepatitis and of adenovirus infections based on laboratory data and clinical coding. We relaxed the stringent case definition adopted during the AS-Hep-UA to identify all cases of acute hepatitis with unknown aetiology (termed AHUA). We compared events within the outbreak period (defined as 1st Oct 2021—31 Aug 2022) to the rest of our study period.
Results
Over the study period, there were 903,433 acute presentations overall, of which 391 (0.04%) were classified as AHUA. AHUA episodes had significantly higher critical care admission rates (p < 0.0001, OR = 41.7, 95% CI:26.3–65.0) and longer inpatient admissions (p < 0.0001) compared with the rest of the patient population. During the outbreak period, significantly more adults (≥ 16 years) were diagnosed with AHUA (p < 0.0001, OR = 3.01, 95% CI: 2.20–4.12), and there were significantly more human adenovirus (HadV) infections in children (p < 0.001, OR = 1.78, 95% CI:1.27–2.47). There were also more HAdV tests performed during the outbreak (p < 0.0001, OR = 1.27, 95% CI:1.17–1.37). Among 3,707 individuals who were tested for HAdV, 179 (4.8%) were positive. However, there was no evidence of more acute hepatitis or increased severity of illness in HadV-positive compared to negative cases.
Conclusions
Our results highlight an increase in AHUA in adults coinciding with the period of the outbreak in children, but not linked to documented HAdV infection. Tracking changes in routinely collected clinical data through EHR could be used to support outbreak surveillance.
Funder
The Francis Crick Institute
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. World Health Organization, Disease Outbreak News: Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland. 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON368#.
2. Morfopoulou S, Buddle S, Montaguth OET, Atkinson L, Guerra-Assunção JA, Marjaneh MM, et al. Genomic investigations of unexplained acute hepatitis in children. Nature. 2023. https://doi.org/10.1038/s41586-023-06003-w.
3. Ho A, Orton R, Tayler R, Asamaphan P, Herder V, Davis C, et al. Adeno-associated virus 2 infection in children with non-A-E hepatitis. Nature. 2023. https://doi.org/10.1038/s41586-023-05948-2.
4. Servellita V, Gonzalez AS, Lamson DM, Foresythe A, Huh HJ, Bazinet AL, et al. Adeno-associated virus type 2 in US children with acute severe hepatitis. Nature. 2023. https://doi.org/10.1038/s41586-023-05949-1.
5. Matthews PC, Campbell C, Săndulescu O, Matičič M, Ruta SM, Rivero-Juárez A, et al. Acute severe hepatitis outbreak in children: A perfect storm. What do we know, and what questions remain? 2022.